Literature DB >> 163220

Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells.

A S Russell, J S Percy, T Kovithavongs.   

Abstract

We assessed cell-mediated immunity to herpes simplex virus type 1 antigen in patients suffering from recurrent cold sores and in a series of healthy controls. Paradoxically, all those subject to recurrent herpetic infections had, without exception, evidence of cell-mediated immunity to herpes antigens. This was demonstrated by lymphocyte transformation and specific 51Cr release from infected human amnion cells after incubation with peripheal blood mononuclear cells. Where performed, skin tests with herpes antigen were also positive. In addition, serum from these patients specifically sensitized herpesvirus-infected cells to killing by nonimmune, control mononuclear cells. These tests were negative in the control patients except in a few cases, and it is suggested that these latter may be the asymptomatic herpesvirus carriers previously recognized or that they may have experienced a genital infection.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 163220      PMCID: PMC415070          DOI: 10.1128/iai.11.2.355-359.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Studies on herpes simplex virus. VI. Observations on patients with recurrent herpetic lesions injected with herpes viruses or their antigens.

Authors:  E JAWETZ; M F ALLENDE; V R COLEMAN
Journal:  Am J Med Sci       Date:  1955-05       Impact factor: 2.378

2.  An attempt to vaccinate against herpes simplex.

Authors:  S G ANDERSON; J HAMILTON; S WILLIAMS
Journal:  Aust J Exp Biol Med Sci       Date:  1950-09

3.  Cell-mediated immunity to Varicella-Zoster antigen in acute Herpes zoster (shingles).

Authors:  A S Russell; R A Maini; M Bailey; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

4.  Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells.

Authors:  F A Ennis
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

5.  Use of the 51 Cr release test to demonstrate patterns of antibody response in humans to herpesvirus types 1 and 2.

Authors:  J W Smith; E Adam; J L Melnick; W E Rawls
Journal:  J Immunol       Date:  1972-09       Impact factor: 5.422

6.  Interferon levels and resistance to viral infection associated with selected interferon inducers.

Authors:  F F Pindak; J P Schmidt; D J Giron; P T Allen
Journal:  Proc Soc Exp Biol Med       Date:  1971-10

Review 7.  Viral infections in man associated with acquired immunological deficiency states.

Authors:  T C Merigan; D A Stevens
Journal:  Fed Proc       Date:  1971 Nov-Dec

8.  Contactual lysis of antibody-coated chicken erythrocytes by purified lymphocytes.

Authors:  P Perlmann; H Perlmann
Journal:  Cell Immunol       Date:  1970-09       Impact factor: 4.868

9.  Prevention of cell-to-cell spread of herpes simplex virus by leukocytes.

Authors:  D L Lodmell; A Niwa; K Hayashi; A L Notkins
Journal:  J Exp Med       Date:  1973-03-01       Impact factor: 14.307

10.  THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. II. A CELLULAR BASIS FOR THE DEVELOPMENT OF RESISTANCE WITH AGE.

Authors:  R T JOHNSON
Journal:  J Exp Med       Date:  1964-09-01       Impact factor: 14.307

View more
  23 in total

1.  Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses.

Authors:  L A Babiuk; B T Rouse
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

2.  Depressed specific cell-mediated immunity to Herpes simplex virus type 1 in patients with recurrent herpes labialis.

Authors:  Y H Thong; M M Vincent; S A Hensen; D A Fuccillo; M Rola-Pleszczynski; J A Bellanti
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

3.  Antibody-dependent cellular protection against herpes simplex virus dissemination as revealed by viral plauqe and infectivity assays.

Authors:  F Shimizu; K Hanaumi; Y Shimizu; K Kumagai
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

4.  Pathogenetic mechansims of recurrent herpes simplex virus infections.

Authors:  R J Klein
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

5.  Suppression of in vitro growth of virulent and avirulent herpes simplex viruses by cell-mediated immune mechanisms, antibody, and interferon.

Authors:  F Shimizu; J Satoh; M Tada; K Kumagai
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

6.  Effect of thymopentin on the mortality and immune response after an experimental herpes simplex infection in mice.

Authors:  R Cappel; F de Cuyper; K De Neef; W Höbel; K Bolla
Journal:  Surv Immunol Res       Date:  1985

7.  The effects of prednisolone in leucocyte function in man. A double blind controlled study.

Authors:  J R Clarke; R F Gagnon; F M Gotch; M R Heyworth; I C Maclennan; S C Truelove; C A Waller
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

8.  Murine cellular cytotoxicity to syngeneic and xenogeneic herpes simplex virus-infected cells.

Authors:  S Kohl; D B Drath; L S Loo
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

9.  Human polymorphonuclear leucocytes as mediators of antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells.

Authors:  J M Oleske; R B Ashman; S Kohl; S L Shore; S E Starr; P Wood; A J Nahmias
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

10.  Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies.

Authors:  A Moller-Larsen; I Heron; S Haahr
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.